Physician profile
Pradeep K Sinha
NPI 1144203233
$6,630.23
in general payments reported to CMS, 2019-2025
22 companies · $647 in 2025
The $647 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $455 · 2020: $749 · 2021: $978 · 2022: $1,883 · 2023: $862 · 2024: $1,056 · 2025: $647.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,470 · Education: $68.16 · Travel and Lodging: $26.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,469.58 |
| Education | $68.16 |
| Travel and Lodging | $26.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $964.86 | 2021-2022 | |
| Galderma Laboratories, L.P. | $661.07 | 2020-2025 | Dysport |
| Allergan, INC. | $639.38 | 2019-2022 | |
| Abbvie INC. | $483.11 | 2023-2025 | Botox |
| Aerin Medical INC. | $466.68 | 2019-2025 | |
| Genzyme Corporation | $436.50 | 2020-2025 | |
| Intersect Ent, INC. | $400.39 | 2020-2022 | |
| Optinose US, INC. | $400.34 | 2019-2023 | |
| Stryker Corporation | $398.91 | 2019-2022 | |
| Inspire Medical Systems, INC. | $379.74 | 2023-2024 | Inspire |
| Regeneron Healthcare Solutions, INC. | $370.10 | 2020-2025 | Dupixent |
| Medtronic, INC. | $328.98 | 2023-2025 | Propel, Nuvent, Nim Vital |
| Karl Storz Endoscopy-America | $163.62 | 2020 | |
| Cochlear Americas | $142.81 | 2022-2024 | Osia Osi300 Implant, Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode |
| Pentax of America, INC. | $103.69 | 2023 | N/A |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alk-Abello, INC | $102.56 | 2019-2023 | Grastek, Ragwitek, Odactra |
| Musculoskeletal Transplant Foundation INC. | $69.03 | 2021-2023 | |
| Spirair, INC. | $48.36 | 2025 | |
| Acclarent, INC | $20.93 | 2020 | |
| Phadia US INC. | $18.46 | 2022 | |
| Smith+Nephew, INC. | $17.70 | 2025 | Rf20000 |
| Baxter Healthcare | $13.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pradeep Sinha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.